Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB.
All Topics

Multi-drug Resistant Tuberculosis

MSF Pharmacist dispensing Bedaquiline and Delamanid based DRTB
Multi-drug Resistant Tuberculosis

TB-PRACTECAL: Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis

Press Release 21 Dec 2022
MSF, Doctors without Borders, Daily dosage of pills
Multi-drug Resistant Tuberculosis

Major opportunity to increase access to newer, safer DR-TB drugs is at risk

Press Release 7 Nov 2022
MSF Hospital in Bangassou, CAR

MSF warns that supply delays of critical TB test will cost lives

Press Release 15 Sep 2022
Simphiwe holds his medication, he takes up to 26 pills a day to treat XDR-TB. Here he holds his morning selection, which includes delamanid, one of the newest DR-TB drugs, which Simphiwe is taking for the first time today.
Drug-resistant TB

MSF response: WHO announces positive change to TB treatment guidelines

Press Release 4 May 2022
Sinethemba was one of the first patients that our MSF team put on delamanid, treatment for TB.
Multi-drug Resistant Tuberculosis

TB-PRACTECAL: MSF clinical trial finds short, effective and safe drug-resistant tuberculosis treatment

Press Release 20 Oct 2021
Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB.

Trial of MDR-TB treatment ends enrolment early after after positive initial data

Press Release 24 Mar 2021